Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Executives On The Move

Set Alert for Executives on The Move

Executives On The Move: New SVP Of Oncology Clinical Research At Gilead, While EyeGate Gets New CEO

New chief medical officer at SpringWorks Therapeutics, while Biomea Fusion gets new chief financial officer.

Appointments BioPharmaceutical

Executives On The Move: New Chief Scientific Officers At Almirall And FibroGen

Chief brand officer joins Moderna, plus new chief medical officer at Monopar Therapeutics.

Appointments BioPharmaceutical

Executives On The Move: New Chief Financial Officer Joins BioNTech, While Moderna Picks Up New Chief Medical Officer

Merck Gets New Chief Strategy Officer, New Chief Operating And Production Officer At CureVac.

Appointments Leadership

GSK's Oncology R&D Chief Axel Hoos Jumps To Lead Scorpion

Axel Hoos will become the CEO of a Boston-based cancer start-up focusing on targeted precision drugs. He talked to Scrip about the decision to leave GSK after 10 years.

Leadership Companies

Executives On The Move: New CEOs For Lengo, Draupnir And OncoSec

Leadership moves are also reported at CureVac, while Esperion Therapeutics and Palatin Technologies get new chief medical officers.

Appointments BioPharmaceutical

Pharma Veteran Sørensen To Help Guide Ferring's Growth Plans

After more than three decades being associated with Novo Nordisk, Lars Rebien Sørensen has signed up to be chairman of Ferring, telling Scrip that the privately owned Swiss group's philosophy chimes with his own.

Leadership Business Strategies

AstraZeneca’s Susan Galbraith To Lead Its Entire Cancer R&D

After more that 10 years at the firm, Susan Galbraith has taken on an expanded role heading up oncology R&D at AstraZeneca.

Appointments Companies

Executives On The Move: New Chief Financial Officers At Intercept Pharmaceuticals, C4 Therapeutics And Pascal Biosciences

Kymera Therapeutics appoints new chief business officer, while Lineage Cell Therapeutics gets new finance director.

Appointments BioPharmaceutical

Executives On The Move: New Chief Scientific Officers At Sigilon, Sensorion And IMV

Astrea Pharmaceuticals appoints new CEO, while new chief medical officers join Intercept and Onconova.

Appointments BioPharmaceutical

Executives On The Move: Organon Appoints Leadership Team, Xenon Pharmaceuticals Reshuffles Management, And More

Brooklyn ImmunoTherapeutics appoints chief scientific officer, while new chief business officer joins 4D Molecular Therapeutics.

Appointments Leadership

Executives On The Move: New CEOs At Shield and Alligator Therapeutics While Vaccibody Picks up New Chief Scientific Officer

New chief medical officer joins Zhaoke Ophthalmology, new chief financial officer at Evelo Biosciences.

Appointments BioPharmaceutical
See All